Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Accounts Payables: 2023-2024

Historic Accounts Payables for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $1.2 million.

  • Sagimet Biosciences' Accounts Payables fell 32.31% to $1.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.2 million, marking a year-over-year decrease of 32.31%. This contributed to the annual value of $186,000 for FY2023, which is N/A change from last year.
  • Sagimet Biosciences' Accounts Payables amounted to $1.2 million in Q3 2024, which was down 42.23% from $2.0 million recorded in Q2 2024.
  • Sagimet Biosciences' 5-year Accounts Payables high stood at $2.7 million for Q2 2023, and its period low was $186,000 during Q4 2023.
  • Over the past 2 years, Sagimet Biosciences' median Accounts Payables value was $1.4 million (recorded in 2023), while the average stood at $1.4 million.
  • Data for Sagimet Biosciences' Accounts Payables shows a maximum YoY plummeted of 32.31% (in 2024) over the last 5 years.
  • Over the past 2 years, Sagimet Biosciences' Accounts Payables (Quarterly) stood at $186,000 in 2023, then plummeted by 32.31% to $1.2 million in 2024.
  • Its Accounts Payables stands at $1.2 million for Q3 2024, versus $2.0 million for Q2 2024 and $531,000 for Q1 2024.